Quinton Marine Plasma (Seawater Minerals)
Quinton Marine Plasma (Seawater Minerals) scored 5.9 / 10 (👍 Worth trying) on the BioHarmony scale as a Substance → Vitamin / Mineral / Nutrient.
Quinton Marine Plasma is cold-microfiltered deep seawater sold as a full-spectrum electrolyte and trace-mineral supplement in isotonic and hypertonic ampoules. No modern controlled trial has tested the branded product for any disease. The nearest real human evidence is seawater nasal irrigation for allergic rhinitis (4 RCTs, 351 patients, symptom score improved per Li 2019) and magnesium-rich deep-sea water for insulin resistance and LDL (HOMA-IR fell, p=0.049, per Ham 2020).
What is Quinton Marine Plasma (Seawater Minerals)?
Quinton Marine Plasma is cold-microfiltered deep seawater sold as a full-spectrum electrolyte and trace-mineral supplement, packaged in 10 mL glass ampoules in two strengths. It is for people who want a clean, complete mineral and electrolyte source rather than a single isolated mineral, and the score sits in the worth-trying band because the safety profile is benign and the mechanism is sound, while the product-specific human evidence is thin. The honest read: no modern controlled trial has tested the branded product, and the nearest real data is seawater nasal irrigation for rhinitis (4 RCTs, 351 children, symptom score improved per Li 2019) plus magnesium-rich deep-sea water for insulin resistance (HOMA-IR fell, p=0.049, per Ham 2020).
The isotonic form is roughly one-third seawater diluted with spring water to about 9 g/L, which puts it near 0.9 percent saline and close to the osmolarity of blood plasma, so it is positioned for everyday remineralization and oral hydration. The hypertonic form is undiluted seawater at about 33 g/L, carrying a much higher mineral and sodium load. The supplement supplies sodium, magnesium, potassium, calcium and dozens of trace minerals at native seawater ratios. Its marketing heritage traces to Rene Quinton, a French physiologist who argued in 1904 that the body's internal fluid mirrors ancestral seawater. That analogy is historical, not an approved medical claim.
Terminology
This report turns on a few distinctions that decide how you should read the evidence. The biggest one is that almost none of the supporting studies actually tested Quinton; they tested adjacent products like deep-sea mineral water or seawater nasal sprays. The isotonic versus hypertonic split matters for sodium load, and the deep-sea-water proxy matters because its benefits track magnesium, not the marine-plasma mystique.
- Marine plasma: Cold-microfiltered, sterilized deep seawater sold as a drinking supplement; also called plasma de Quinton or seawater minerals.
- Isotonic: A solution matched to the body's fluid concentration, here about 9 g/L (near 0.9 percent saline), used for hydration and remineralization.
- Hypertonic: A more concentrated solution, here undiluted seawater at about 33 g/L, with a higher mineral and sodium load.
- Osmolarity: The concentration of dissolved particles in a fluid; isotonic seawater approximates the osmolarity of plasma.
- Deep-sea water: Seawater drawn from depth (often 600 to 1500 m), the product used in most of the proxy human trials, distinct from Quinton ampoules.
- HOMA-IR: Homeostatic Model Assessment of Insulin Resistance, a fasting insulin and glucose calculation used to gauge insulin sensitivity.
- RCT: Randomized Controlled Trial, the design that randomizes participants to intervention or control.
- NOSE score: Nasal Obstruction Symptom Evaluation, a validated questionnaire for nasal blockage.
- SCFA: Short-Chain Fatty Acids, gut-bacteria metabolites used as a marker of intestinal health.
How do you take Quinton Marine Plasma (Seawater Minerals)?
Dosing & Protocols
Dosing information is summarized from published research and community reports. This is not a prescribing guide. Consult a healthcare provider before starting any protocol.
Routes & Forms
| Route | Form | Clinical Range | Community Range |
|---|---|---|---|
| Oral isotonic ampoule | 10 mL glass ampoule, deep seawater diluted to plasma osmolarity (about 9 g/L) | 1 to 3 ampoules/day | 1 to 6 ampoules/day |
| Oral hypertonic ampoule | 10 mL glass ampoule, undiluted deep seawater (about 33 g/L) | 1 to 3 ampoules/day | 1 to 3 ampoules/day |
Protocols
Everyday remineralization Anecdotal
- Dose
- 1 isotonic ampoule
- Frequency
- Once daily
- Duration
- Ongoing
Most common practitioner and user pattern. Pairs with a mineral-poor or low-sodium whole-food diet.
Short hypertonic push Anecdotal
- Dose
- 1 to 2 hypertonic ampoules
- Frequency
- Daily for a defined block
- Duration
- 2 to 4 weeks
Used around heavy sweating, travel, or perceived mineral depletion. Watch total sodium if other sources are high.
How this score is calculated →
What are the benefits of Quinton Marine Plasma (Seawater Minerals)?
Upside contribution: 1.55
| Dimension | Weight | Score | Visual | Weighted |
|---|---|---|---|---|
| Efficacy | 25% | 2.3 | 0.575 | |
| Breadth | 15% | 2.8 | 0.420 | |
| Evidence | 25% | 2.2 | 0.550 | |
| Speed | 10% | 3.0 | 0.300 | |
| Durability | 10% | 2.5 | 0.250 | |
| Bioindividuality | 15% | 3.0 | 0.450 | |
| Total | 2.545 |
Upside Rationale
The upside comes mostly from mechanism and tolerability rather than from product-specific outcomes. The strongest benefit cluster is electrolyte and trace-mineral repletion, and the strongest human evidence is a magnesium effect borrowed from deep-sea-water trials, not from Quinton itself. The key boundary condition runs through every dimension: the evidence that exists tested a different product or a different route, so the upside is real but modest and indirect.
Efficacy (2.3/5.0): The single strongest citable finding is that magnesium-rich deep-sea water lowered LDL by a significant margin (p=0.003) and HOMA-IR (p=0.049) in 37 prediabetic adults over 8 weeks in Ham 2020, replicated for insulin resistance in 75 adults in Ham 2024. But these used 350 mg of magnesium per day, far more mineral than a 10 mL Quinton ampoule delivers, and the active lever was magnesium, not the marine-plasma matrix. For the branded product, real-world clinical magnitude is small: hydration and electrolyte support you can feel, modest mineral repletion, and nothing disease-modifying. The grand historical claims outrun the product-specific outcome data, which lands efficacy in the low-moderate range.
Breadth of Benefits (2.8/5.0): The plausible reach touches several systems, which lifts breadth above efficacy. Metabolic health and lipids have the magnesium-water signal (Ham 2024, HOMA-IR p=0.0102); the gut has one decent trial at high volume (Takeuchi 2020, constipation improvement 94 vs 60 percent); the upper respiratory tract has genuine rhinitis RCTs by the irrigation route (Li 2019); and hydration and recovery have tiny crossover studies. The boundary is that each endpoint rests on a proxy product or a different route, so breadth reflects mechanistic plausibility across systems more than confirmed multi-system benefit from Quinton.
Evidence Quality (2.2/5.0): No modern placebo-controlled trial tested the branded Quinton product for any endpoint, which is the central limitation and the reason this dimension sits in the thin-but-not-implausible band. The supporting body is a proxy literature on deep-sea or deep-ocean mineral water, mostly small (many under 100 participants) and substantially from one Korean group, plus seawater nasal-irrigation RCTs that test sprays rather than drinking ampoules. There is no integrity scandal or fraud to penalize, so this is not an integrity haircut; it is simply a sparse, indirect base. Confidence is Low for the product specifically and moderate for the underlying electrolyte and magnesium mechanism.
Speed of Onset (3.0/5.0): Electrolyte and hydration effects are immediate to a few hours, the same as any mineral drink, so any felt change in hydration or cramping shows up fast. The measurable biomarker shifts in the proxy trials were slower, appearing over 8 to 12 weeks of daily magnesium-rich deep-sea water in the Ham 2020 studies. Because no trial used Quinton ampoules, both timelines are borrowed, but the acute electrolyte action is mechanistically certain.
Durability (2.5/5.0): Benefits depend on continued intake. Mineral and electrolyte repletion is a flow, not a stock, so stopping returns status to baseline within days for hydration and over weeks for any mineral-status change. None of the proxy trials showed a lasting effect after withdrawal, and there is no reason to expect Quinton to produce a durable change once discontinued.
Bioindividuality Upside (3.0/5.0): The strongest responders are people who are genuinely mineral-poor or magnesium-deficient, heavy sweaters and athletes losing electrolytes, and those eating a low-sodium or mineral-poor whole-food diet, where repletion has the most room to help. Weak responders are mineral-replete people eating a varied diet, for whom an ampoule adds little. The deep-sea-water metabolic signal in Ham 2020 appeared in prediabetic adults, hinting that metabolically stressed users may see more, but this is inference from a proxy product rather than a validated responder marker for Quinton.
What are the risks & downsides of Quinton Marine Plasma (Seawater Minerals)?
Downside contribution: 0.81 (safety risks weighted extra)
| Dimension | Weight | Score | Visual | Weighted |
|---|---|---|---|---|
| Safety | 30% | 1.8 | 0.540 | |
| Side effects | 15% | 1.8 | 0.270 | |
| Cost | 5% | 2.8 | 0.140 | |
| Effort | 5% | 1.5 | 0.075 | |
| Opportunity | 5% | 2.5 | 0.125 | |
| Dependency | 15% | 1.2 | 0.180 | |
| Reversibility | 25% | 1.2 | 0.300 | |
| Total | 1.630 | |||
| Harm subtotal × 1.4 | 1.806 | |||
| Opportunity subtotal × 1.0 | 0.340 | |||
| Combined downside | 2.146 | |||
| Baseline offset (constant) | −1.340 | |||
| Effective downside penalty | 0.806 |
Downside Rationale
The downside is genuinely low, which is the other half of why this lands in the worth-trying band rather than lower. The dominant concern is not harm but opportunity cost and price: the documented benefits track magnesium and minerals you can buy more cheaply, so the question is value, not safety. The one real harm-side caveat is the sodium in the hypertonic form, which is modest and concentrated in a specific population.
Safety Risk (1.8/5.0): There is no intrinsic catastrophic risk, no FDA or EFSA enforcement action, no recall, and no FAERS signal for the product. A 32-week double-blind RCT in 93 older women using microfiltered seawater reported no severe or moderate adverse events per Babiloni-Lopez 2024, and systolic blood pressure actually fell in the training arms. The only meaningful safety consideration is the hypertonic form's sodium load, which is an interaction with sodium-sensitive physiology and renal limitation rather than an intrinsic toxin. Scored at a properly used, clean-sourced baseline with the isotonic form as the everyday default, intrinsic safety risk is low.
Side Effect Profile (1.8/5.0): Side effects are minimal and reversible. At isotonic doses most people notice nothing beyond a salty taste. The hypertonic form can add a perceptible sodium load that may cause thirst or transient puffiness in salt-sensitive users, and very high ampoule counts could in principle contribute to mineral excess, though this was not seen in the trials, including the 32-week Babiloni-Lopez 2024 safety study. There is no documented pattern of GI, neurological, or systemic adverse effects from label-dose use.
Financial Cost (2.8/5.0): A 30-ampoule box runs about $50, so one ampoule a day costs roughly $45 to $50 per month, with subscription pricing slightly lower. Higher protocols of three to six ampoules push the cost to $100 to $300 per month. That is a premium for a mineral source: a dedicated magnesium supplement delivering the same active dose used in the trials costs a fraction of this.
Time/Effort Burden (1.5/5.0): Effort is trivial. Snap an ampoule, hold it briefly under the tongue, and swallow. There is no cycling requirement, no titration, and no preparation. The only minor friction is the glass ampoule format, which a few users find fiddly.
Opportunity Cost (2.5/5.0): The real cost is that Quinton can crowd out cheaper, better-targeted options. The documented metabolic and lipid benefits in the proxy literature tracked magnesium, which a standard magnesium supplement supplies at a small fraction of the price, and basic electrolyte needs are met by ordinary salt and food. Quinton's distinct value is the full-spectrum trace-mineral matrix and a clean isotonic hydration form, so the opportunity cost is moderate: you may be paying a premium for completeness and convenience rather than a unique effect.
Dependency/Withdrawal (1.2/5.0): There is no dependency, tolerance, craving, or withdrawal syndrome. Minerals and electrolytes do not produce adaptation that creates a need to continue, and stopping simply returns mineral intake to baseline.
Reversibility (1.2/5.0): Effects are fully and cleanly reversible. Stopping causes no rebound and no lasting change; hydration status normalizes within days and there is nothing permanent to taper.
Is Quinton Marine Plasma (Seawater Minerals) worth it?
Quinton Marine Plasma is a clean, benign, full-spectrum electrolyte and trace-mineral source that earns a worth-trying 5.9 mostly on safety and mechanism, not on product-specific proof. The honest framing: no modern controlled trial has tested the branded product, the nearest real evidence tracks magnesium-rich deep-sea water (Ham 2024) and seawater nasal sprays rather than Quinton ampoules, and the documented benefits can be had more cheaply from a targeted magnesium or electrolyte product. It is a reasonable choice for someone who values a complete mineral matrix and a clean isotonic hydration form and who is willing to track one marker to decide whether it earns its place. It is a poor choice for anyone expecting the century-old marine-plasma mystique to translate into a disease-modifying effect.
✅ Best for: People who are genuinely mineral-poor or eat a low-sodium, mineral-poor whole-food diet and want easy repletion; heavy sweaters and athletes wanting a clean electrolyte and trace-mineral source for hydration and recovery; metabolically stressed users targeting insulin sensitivity who will track fasting insulin or HOMA-IR and accept that the lever is largely magnesium; people who specifically prefer a full-spectrum seawater matrix over isolated minerals and value the clean isotonic format; and tinkerers who will define one marker up front and stop if it does not move.
❌ Avoid if: You have hypertension, kidney failure or renal impairment, or are on a sodium-restricted diet, especially with the hypertonic form, because of the sodium and mineral load; you are pregnant or breastfeeding, where manufacturer labels advise clinician clearance; you are dosing an infant, which should only happen under clinician direction given the hypertonic sodium load; you are simply seeking a cheap magnesium effect, since a dedicated magnesium supplement is far better value; or you expect marine plasma to treat a specific disease, which no controlled evidence supports.
What is Quinton Marine Plasma (Seawater Minerals) best for?
The overall BioHarmony score reflects the intervention's primary evidence profile. These subratings are independent assessments per use case.
Cardiovascular: 5.5/10
Score: 5.5/10Marine plasma earns 5.5/10 for cardiovascular because the nearest human signal is a deep-sea-water proxy, not the branded product. Ham 2020 ran a double-blind crossover RCT in 37 prediabetic adults using magnesium-rich deep-sea water (350 mg magnesium daily, 8 weeks) and found total cholesterol fell (p=0.006) and LDL fell (p=0.003). An animal study in hypertensive rats lowered blood pressure, but there is no human blood-pressure trial of Quinton. The effect tracks magnesium intake more than the marine-plasma framing, so a magnesium-tracked mineral water is the honest comparison. Pick this only if you define a lipid or blood-pressure target up front and stop if it does not move.
Metabolic Health: 5.5/10
Score: 5.5/10The metabolic-health case lands at 5.5/10 on the strength of one replicated lab line. Ham 2024 randomized 75 adults to 350 mg magnesium per day from deep-seawater extract for 12 weeks and saw HOMA-IR fall (p=0.0102), fasting insulin fall (p=0.0238), and C-peptide fall (p=0.0220), while HbA1c and glucose did not move. The earlier Ham 2020 crossover agreed. The honest reading: this is a magnesium effect from one Korean group, replicable mainly within that lab, and never tested as Quinton ampoules. Track fasting insulin if metabolic health is your goal, and treat cheaper magnesium as the realistic benchmark.
Blood Sugar / Glycemic Control: 5.0/10
Score: 5.0/10Blood-sugar control scores 5.0/10 because the insulin-sensitivity signal is real but glucose itself rarely moves. In Ham 2024 (75 adults, 12 weeks, 350 mg magnesium) HOMA-IR and fasting insulin both fell, yet fasting glucose and HbA1c were unchanged; Ham 2020 likewise found no glucose effect. So the benefit sits upstream at insulin handling, not at the glucose number most people watch. None of this used Quinton, and the active lever is magnesium. Define fasting insulin or HOMA-IR as your endpoint rather than a continuous glucose monitor reading, and benchmark against a dedicated magnesium product.
Gut Health / Microbiome: 5.0/10
Score: 5.0/10Gut health earns 5.0/10 on a single decent trial of refined deep-sea water, not Quinton. Takeuchi 2020 randomized 98 adults to 1 liter per day of refined deep-sea water for 12 weeks and reported constipation improvement in 94 percent versus 60 percent of controls (p less than 0.05) with higher short-chain fatty acids and lower fecal phenols. That is a meaningful GI result, but it used a full liter daily, far more than a 10 mL ampoule delivers, so dose translation to Quinton is weak. If regularity is the goal, the trial supports drinking volume of mineral water more than it supports concentrated ampoules.
Immune Function: 5.0/10
Score: 5.0/10Immune function rates 5.0/10 by way of the rhinitis literature, which is the strongest real seawater evidence but tests a different route. Li 2019 pooled 4 RCTs and 351 children and found hypertonic saline nasal irrigation improved nasal symptom score (mean difference 1.82, p=0.02) and cut rescue antihistamine use (RR 0.68, p=0.02). Wang 2020 agreed across children and adults. This is genuine mucosal and barrier support, but it is seawater up the nose, not Quinton swallowed, so the immune read is borrowed and should be treated as adjacent rather than product-specific.
Respiratory: 5.0/10
Score: 5.0/10Respiratory and nasal support scores 5.0/10 because seawater irrigation is the one area with replicated RCTs. Kosec 2025 randomized 64 athletes to isotonic seawater and saw subjective nasal obstruction improve (NOSE score 5.24 to 2.78 versus 5.24 to 4.61, p=0.006), though objective peak nasal inspiratory flow did not differ. Li 2019 found hypertonic beat isotonic for symptom relief. The catch is identical to the immune case: these trials irrigate the nose with seawater sprays, which is not the Quinton drinking ampoule, so the score reflects the modality, not the branded oral product.
| Use Case | Score | Summary |
|---|---|---|
| ○ Body Composition / Fat Loss | 4.5 | Hydration and electrolyte support around training is plausible, but no trial shows Quinton changes fat mass or lean mass. The proxy magnesium-water lipid data is metabolic, not body-composition. |
| ○ Endurance / Cardio | 4.5 | Two very small crossover studies (N of 8 to 9) suggested faster rehydration and recovery with deep-ocean mineral water, but the samples are too small to lean on and never used Quinton. |
| ○ Recovery / Repair | 4.5 | Post-exercise rehydration and recovery signals exist in tiny crossover trials (Stasiule 2014, Keen 2016), but N of 8 to 9 and a different product make this suggestive at best. |
| ○ Energy / Fatigue | 4.0 | Some users report a hydration or energy lift, but there is no controlled trial of Quinton for fatigue, and the mineral dose per ampoule is modest. |
| ○ Skin / Beauty | 4.0 | A 33-person uncontrolled before-and-after in atopic dermatitis (Hataguchi 2005) reported skin improvement and shifted mineral status, but the absence of a control arm makes it weak evidence. |
| ○ Geriatric / Aging Population | 4.0 | Babiloni-Lopez 2024 gave 93 older women microfiltered seawater alongside resistance training over 32 weeks with no adverse events and blood pressure that fell in training arms; the benefit tracked the exercise, not clearly the seawater. |
| ○ Anti-Inflammatory | 3.5 | Nasal irrigation reduces local inflammatory symptoms, but there is no systemic anti-inflammatory marker trial of the oral product. |
| ○ Longevity / Lifespan | 3.0 | No human longevity or healthspan endpoint has been tested. The pitch rests on historical mystique, not outcome data. |
| ○ Healthspan | 3.0 | Mineral adequacy supports general health, but there is no direct healthspan trial of marine plasma. |
| ○ Liver / Detoxification | 3.0 | Hataguchi 2005 noted lower hair levels of toxic minerals, but this is not a controlled detoxification endpoint and the report avoids detox framing. |
| ○ Antioxidant / Oxidative Stress | 3.0 | Trace minerals support antioxidant enzyme cofactors in theory, but no human oxidative-stress marker trial tested Quinton. |
| ○ Stress / Resilience | 3.0 | Magnesium can support stress physiology, but the ampoule dose is modest and untested for this endpoint. |
| ○ Sleep Quality | 3.0 | No controlled sleep data. Any benefit would be an indirect magnesium effect at a small dose. |
| ○ Bone / Joint Health | 3.0 | Calcium and magnesium contribute to bone biology generally, but no bone or joint endpoint trial used marine plasma. |
Frequently Asked Questions
What is Quinton Marine Plasma and what does it actually do?
Quinton Marine Plasma is cold-microfiltered deep seawater sold as a full-spectrum electrolyte and trace-mineral supplement. It supplies sodium, magnesium, potassium, calcium and dozens of trace minerals at native seawater ratios. The isotonic form is diluted to match plasma osmolarity for everyday remineralization and hydration; the hypertonic form is undiluted seawater with a higher mineral and sodium load. The marketing frames it as restoring the body's internal sea, an early twentieth-century analogy from physiologist Rene Quinton. In practice it functions as a clean electrolyte and trace-mineral source, not a medicine for any specific disease.
How much Quinton should I take, and isotonic or hypertonic?
Most people take 1 ampoule of 10 mL per day, and labels permit up to 3 daily. Choose isotonic for everyday remineralization and hydration because it carries a lower sodium load. Reserve hypertonic for a short, intentional mineral push, since Original Quinton Hypertonic contains 102 mg sodium per ampoule (about 4 percent of the daily value). Hold it under the tongue briefly, then swallow, ideally on an empty stomach. If you are sodium-sensitive, hypertensive, or have kidney issues, stay on isotonic or clear the hypertonic form with a clinician before starting.
Does the human evidence actually support drinking Quinton?
No modern placebo-controlled trial has tested the branded Quinton product for any disease. The supporting evidence is a proxy literature on deep-sea or deep-ocean mineral water, which is small and mostly from one Korean group. Ham 2020 found magnesium-rich deep-sea water lowered HOMA-IR (p=0.049) and LDL (p=0.003) in 37 prediabetic adults. The strongest real seawater evidence is nasal irrigation for rhinitis, but that tests sprays, not drinking ampoules. So the honest read is modest, indirect, and magnesium-driven rather than proof that Quinton itself works.
Is Quinton Marine Plasma safe to take long term?
At label doses the intrinsic risk is low and no FDA or EFSA action, recall, or adverse-event signal surfaced for the product. A 32-week RCT in 93 older women using microfiltered seawater reported no severe or moderate adverse events per Babiloni-Lopez 2024. The one real caveat is the hypertonic form's sodium: 102 mg per ampoule, up to about 306 mg daily at three ampoules. That is meaningful but not extreme for most people, and a clear reason for sodium-sensitive, hypertensive, or renally impaired users to favor isotonic or check with a clinician.
Who should avoid Quinton Marine Plasma?
Avoid or get clinician clearance if you have hypertension, kidney failure or renal impairment, are on a sodium-restricted diet, or have an iodine intolerance, since the mineral and sodium load can be a problem. Manufacturer labels also advise caution in pregnancy and breastfeeding. Infants should never be self-dosed; the historical infant use was clinician-administered, and the modern hypertonic sodium load is inappropriate without supervision. Healthy adults using the isotonic form at one ampoule a day face little concern, but the sodium-sensitive should still pick isotonic over hypertonic.
Quinton vs a plain electrolyte or magnesium supplement, which is better?
For the documented benefits, a plain magnesium or electrolyte product is the honest benchmark. The lipid and insulin-resistance signals in the deep-sea-water trials tracked magnesium intake, not anything unique to seawater, and you can get 350 mg of magnesium far more cheaply than from ampoules. Quinton's edge is a full-spectrum trace-mineral matrix at native seawater ratios and a clean, well-tolerated isotonic form, which some people prefer for hydration. If cost matters or your goal is a specific mineral, a targeted supplement wins; Quinton is a premium convenience and completeness play.
How fast should I notice anything from Quinton?
Electrolyte and hydration effects are immediate to a few hours, the same as any mineral drink, so any felt boost in hydration or cramping should show up quickly. The measurable biomarker effects in the proxy trials took longer: lipid and insulin-resistance changes appeared over 8 to 12 weeks of daily magnesium-rich deep-sea water. Because no trial used Quinton ampoules, treat both timelines as borrowed. The practical move is to pick one marker, such as how hydrated you feel or a fasting insulin test, and judge over a few weeks rather than expecting a dramatic shift.
Is the marine-plasma-equals-blood-plasma claim true?
It is a historical analogy, not an approved medical claim. Rene Quinton argued over a century ago that the body's internal fluid mirrors ancient seawater, and isotonic seawater does share a broad mineral and osmolarity resemblance to extracellular fluid. But seawater is not blood plasma: plasma contains proteins, glucose, buffering systems, and tightly regulated electrolyte concentrations that seawater does not match. Modern medicine abandoned the seawater-injection therapy, and even Wikidata describes the Quinton serum as abandoned. Treat the framing as marketing heritage; the real value is as a clean electrolyte and trace-mineral source.
What could change Quinton Marine Plasma (Seawater Minerals)'s score?
BioHarmony scores are living assessments. New research, regulatory changes, or personal context can shift the score up or down. These are the most likely scenarios that would change this intervention's rating.
The most plausible update that moves this score is a real placebo-controlled trial of the branded Quinton product on a defined endpoint, which would shift Evidence first and pull Efficacy with it. A clean positive trial could lift it toward the strong-recommend edge; a null product-specific trial would temper Efficacy and confidence without changing the benign safety picture. Smaller moves would come from larger replication of the magnesium-water metabolic signal or from new safety data on the hypertonic sodium load.
| Scenario | Dimension shifts | New Score |
|---|---|---|
| A well-powered RCT tests Quinton ampoules on a defined endpoint and is clearly positive | Evidence 2.2 to 3.5, Efficacy 2.3 to 3.3 | 6.9 / 10 👍 Worth trying |
| Multiple independent groups replicate the deep-sea-water metabolic and lipid benefit at translatable doses | Evidence 2.2 to 3.0, Breadth 2.8 to 3.3 | 6.4 / 10 👍 Worth trying |
| A product-specific trial of Quinton returns a clear null on its headline claims | Efficacy 2.3 to 1.8, Evidence 2.2 to 2.0 | 5.5 / 10 ⚖️ Neutral |
| New data shows the hypertonic sodium load meaningfully raises blood pressure in typical users | Safety 1.8 to 2.6, Side effects 1.8 to 2.4 | 5.4 / 10 ⚖️ Neutral |
| Independent testing finds inconsistent mineral content or contamination across batches | Evidence 2.2 to 1.8, plus a confidence cut to Low | 5.6 / 10 ⚖️ Neutral |
| Both a positive product-specific trial and replicated metabolic benefit arrive together | Evidence 2.2 to 3.8, Efficacy 2.3 to 3.5, Breadth 2.8 to 3.3 | 7.4 / 10 💪 Strong recommend |
Key Evidence Sources
- Li et al. 2019 - Effectiveness of Hypertonic Saline Nasal Irrigation for Alleviating Allergic Rhinitis in Children: A Systematic Review and Meta-Analysis, Journal of Clinical Medicine. Meta-analysis, 4 RCTs, 351 children; hypertonic saline improved nasal symptom score (mean difference 1.82, p=0.02) and cut rescue antihistamine use (RR 0.68, p=0.02).
- Wang et al. 2020 - Role of nasal saline irrigation in the treatment of allergic rhinitis in children and adults: A systematic analysis, Allergologia et Immunopathologia. Systematic review; saline irrigation significantly improved allergic rhinitis symptoms in children and adults; hypertonic may beat isotonic.
- Kosec et al. 2025 - The Impact of Isotonic Seawater on Subjective and Objective Nose Patency in Athletes: A Randomized Controlled Trial, Journal of Clinical Medicine. RCT, 64 athletes; subjective nasal obstruction improved (NOSE 5.24 to 2.78 vs 5.24 to 4.61, p=0.006); objective peak nasal inspiratory flow unchanged.
- Ham et al. 2020 - Natural Magnesium-Enriched Deep-Sea Water Improves Insulin Resistance and the Lipid Profile of Prediabetic Adults: A Randomized, Double-Blinded Crossover Trial, Nutrients. Crossover RCT, 37 adults, 440 mL/day (350 mg magnesium), 8 weeks; HOMA-IR fell (p=0.049), fasting insulin fell (p=0.042), total cholesterol fell (p=0.006), LDL fell (p=0.003), glucose unchanged.
- Ham et al. 2024 - Magnesium from Deep Seawater as a Potentially Effective Natural Product against Insulin Resistance: A Randomized Trial, Medicina. RCT, 75 adults, 350 mg magnesium/day, 12 weeks; HOMA-IR fell (p=0.0102), fasting insulin fell (p=0.0238), C-peptide fell (p=0.0220), HbA1c and glucose unchanged.
- Takeuchi et al. 2020 - Drinking Refined Deep-Sea Water Improves the Gut Ecosystem with Beneficial Effects on Intestinal Health in Humans: A Randomized Double-Blind Controlled Trial, Nutrients. RCT, 98 adults, 1 liter/day, 12 weeks; constipation improvement 94 percent vs 60 percent (p less than 0.05), short-chain fatty acids increased, fecal phenols decreased.
- Stasiule et al. 2014 - Deep mineral water accelerates recovery after dehydrating aerobic exercise: a randomized, double-blind, placebo-controlled crossover study, Journal of the International Society of Sports Nutrition. Crossover RCT, 9 women; VO2max 9 percent higher at 4 hours recovery (p less than 0.05), leg muscle power better at 48 hours; very small sample.
- Keen et al. 2016 - The impact of post-exercise hydration with deep-ocean mineral water on rehydration and exercise performance, Journal of the International Society of Sports Nutrition. Crossover, 8 participants; faster return to baseline hydration and better knee-extension torque recovery vs spring water and sports drink; very small sample.
- Hataguchi et al. 2005 - Drinking deep-sea water restores mineral imbalance in atopic eczema/dermatitis syndrome, European Journal of Clinical Nutrition. Uncontrolled before-and-after, 33 patients, 6 months; skin symptoms improved in 27 of 33, hair toxic minerals decreased; no placebo arm.
- Babiloni-Lopez et al. 2024 - Long-Term Effects of Microfiltered Seawater and Resistance Training on Hepatic Parameters, Inflammation, Oxidative Stress, and Blood Pressure of Older Women: A 32-Week, Double-Blinded, Randomized, Placebo-Controlled Trial, Healthcare. RCT, 93 older women, 20 mL microfiltered seawater before training, 32 weeks; no severe or moderate adverse events; systolic blood pressure fell in resistance-training arms.
- Sheu et al. 2013 - Deep sea water modulates blood pressure and exhibits hypolipidemic effects via the AMPK-ACC pathway: an in vivo study, Marine Drugs. Animal study only (hypertensive rats, hypercholesterolemic rabbits); lowered blood pressure and serum cholesterol. Only blood-pressure evidence and it is not human.
- Quinton 1904 - L'eau de mer, milieu organique, doctoral thesis (Masson, Paris). Primary historical source; Rene Quinton's 1904 thesis arguing seawater mineral composition resembles the body's internal milieu. Historical context, not a controlled trial.
- Stevens 1913 - Further Remarks on Isotonic Sea Water in Therapeutics, Buffalo Medical Journal. Period medical account of isotonic seawater therapeutics from the early-1900s marine-therapy era. Uncontrolled historical case material, not a trial.
What does the evidence say about Quinton Marine Plasma (Seawater Minerals)?
Evidence on this intervention is summarized across three complementary streams: contemporary clinical research, pre-RCT-era pharmacology and observational use, and the traditional medical systems that documented it first. Convergence across streams signals higher confidence; divergence is surfaced honestly.
Modern Clinical Research
Confidence: Low
Citations: Li 2019, Ham 2020, Ham 2024, Takeuchi 2020, Babiloni-Lopez 2024
Traditional Medicine Systems
Confidence: Limited
Citations: Quinton 1904, Stevens 1913
Holistic Evidence for Quinton Marine Plasma (Seawater Minerals)
The modern and traditional lenses agree on tolerability and a plausible electrolyte and remineralization role, but neither supports the branded product as a treatment for any specific condition; the documented benefits track minerals (especially magnesium) and seawater irrigation routes rather than Quinton itself.
What to Track If You Try This
These are the data points that matter most while running a 30-day Experiment with this intervention.
How to read this section
- Pre
- Test or score before starting the protocol. Anchors a baseline.
- During
- Track while running the protocol so you can see if anything is changing.
- Post
- Re-test after a full cycle to confirm the change held.
- Up
- The marker should rise. For most positive outcomes, that is a good sign.
- Down
- The marker should fall. For most positive outcomes, that is a good sign.
- Stable
- The marker should hold steady. Big swings in either direction are a yellow flag.
- Watch
- Direction depends on dose, timing, and your baseline. Pay close attention to the trend.
- N/A
- No expected direction. The entry is there to anchor a baseline reading.
- Primary
- The Pulse dimension most likely to shift. Track this first.
- Secondary
- Also relevant, but a smaller or less consistent shift. Track if Primary is unclear.
Bloodwork to Order
Open These Markers In Your Dashboard
- RBC Magnesium Baseline (pre-protocol) During | Expected Up
- LDL Cholesterol During | Expected Watch
- Blood Pressure During | Expected Watch
- Fasting Insulin During | Expected Watch
Pulse Dimensions to Watch
- Body During | Expected Up | Primary
- Energy During | Expected Watch | Secondary
- Calm During | Expected Stable | Tertiary
Subjective Signals (Daily Voice Card)
- Hydration and thirst Scale 1-5 | During | Expected Up
- Muscle cramps Scale 1-5 | During | Expected Down
- Salt-driven puffiness or thirst on hypertonic Scale 1-5 | During | Expected Watch
Red Flags: Stop and Consult
- Rising blood pressure on the hypertonic form
- Edema, swelling, or excessive thirst suggesting sodium overload
- Any use in infants without clinician direction
📊 How BioHarmony scoring works
BioHarmony translates a weighted expected-value calculation into a reader-facing 0–10 score. Tier bands: Skip 0–2.9, Caution 3.0–4.4, Neutral 4.5–5.7, Worth Trying 5.8–6.9, Strong Recommend 7.0–8.7, Top-tier 8.8–10.0.
Harm-type downsides (safety risk, side effects, reversibility, dependency) carry a 1.4× precautionary multiplier. Harm weighs more than benefit. Opportunity-type downsides (financial cost, time/effort, opportunity cost) are subtracted at face value.
Use case subratings are independent assessments of how well the intervention addresses specific health goals. They are not components of the overall score. Each subrating reflects the scorer's judgment based on use-case-specific evidence, safety, and effect sizes.
Every dimension is evaluated on a 1–5 scale, and the baseline (1) is subtracted before weighting. A perfect intervention with zero downsides contributes zero penalty rather than a residual floor, so top-tier scores are actually reachable.
EV = Upside − Downside
EV = 1.545 − 0.806 = 0.739
Formula v2.0 maps EV = 0 to score 5.0. Above neutral, EV = +4.00 reaches 10.0; below neutral, EV = −5.36 reaches 0.0. Both sides use the full 5-point half-scale.
Score = 5 + (0.739 / 4.00) × 5 = 5.9 / 10
